Methotrexate sodium - Generic Drug Details
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for methotrexate sodium and what is the scope of patent protection?
Methotrexate sodiumis the generic ingredient in twelve branded drugs marketed by Abic, Pharmacia And Upjohn, Hospira, Fresenius Kabi Usa, Abraxis Pharm, Hikma, Norbrook, Pharmachemie Usa, Accord Hlthcare, Eugia Pharma Speclts, Mylan, Pharmachemie Bv, Sagent Pharms Inc, Sandoz Inc, Bristol, Bristol Myers, Bristol Myers Squibb, Azurity, Amneal Pharms, Barr, Duramed Pharms Barr, Eugia Pharma, Lotus Pharm Co Ltd, Strides Pharma, Sun Pharm, and Zydus Pharms, and is included in fifty NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Methotrexate sodium has three patent family members in three countries.
There are three drug master file entries for methotrexate sodium. Twenty-four suppliers are listed for this compound.
Summary for methotrexate sodium
|Drug Master File Entries:||3|
|Finished Product Suppliers / Packagers:||24|
|Raw Ingredient (Bulk) Api Vendors:||52|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in methotrexate sodium?||methotrexate sodium excipients list|
|DailyMed Link:||methotrexate sodium at DailyMed|
Recent Clinical Trials for methotrexate sodium
Identify potential brand extensions & 505(b)(2) entrants
|Andrew E. Place||Phase 1|
|Children's Cancer Research Fund||Phase 1|
Pharmacology for methotrexate sodium
|Drug Class||Folate Analog Metabolic Inhibitor|
|Mechanism of Action||Folic Acid Metabolism Inhibitors|
Anatomical Therapeutic Chemical (ATC) Classes for methotrexate sodium
US Patents and Regulatory Information for methotrexate sodium
International Patents for methotrexate sodium
|Country||Patent Number||Title||Estimated Expiration|
|European Patent Office||2614814||Composition de méthotrexate (Methotrexate composition)||See Plans and Pricing|
|United Kingdom||201200192||See Plans and Pricing|
|Spain||2726524||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.